Swiss perspectives in 10 languages
Login

Reprogramming the immune system

Great strides are being made in the development of treatments that trick the body’s immune system into fighting cancer. At Bern University Hospital, scientists are hoping to use this procedure in the fight against leukemia.

This content was published on
1 minute

A young American girl recently made history by becoming the first child leukemia patient to be successfully treated using a form of the HIV virus that causes Aids to reprogramme the immune system. The treatment being developed in Bern will also encourage the immune system to attack cancer cells, but without also attacking healthy cells and organs. (SRF/swissinfo.ch)

You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

Read more

More

The business of cancer research

This content was published on Market analysts at Connecticut-based IMS Health forecasts the market for cancer products will grow to $75 billion (CHF71 billion) by 2015, an increase of about 40 per cent from the $54 billion it generated in 2009. The ultimate goal for all actors in this profitable market is to find a cure for the disease, which…

Read more: The business of cancer research

More

Drug development’s road gets longer

This content was published on Health authorities have become more cautious and restrictive and require far more substantial documentation, says Stefan Frings, responsible for oncology at Roche’s partnering unit, which buys drug candidates for further development. Decades ago, a therapy would, for example, be approved for any type of solid tumour, based on relatively limited data. Nowadays, medicines are only…

Read more: Drug development’s road gets longer

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR